tiprankstipranks
Trending News
More News >
Chemung Financial (CHMG)
NASDAQ:CHMG
US Market
Advertisement

Chemung Financial (CHMG) AI Stock Analysis

Compare
112 Followers

Top Page

CHMG

Chemung Financial

(NASDAQ:CHMG)

Rating:72Outperform
Price Target:
$56.00
▲(5.22% Upside)
Chemung Financial's overall score reflects stable financial performance and positive technical indicators. The company's strategic initiatives and dividend increases are positive, but high valuation and declining revenue growth are concerns.

Chemung Financial (CHMG) vs. SPDR S&P 500 ETF (SPY)

Chemung Financial Business Overview & Revenue Model

Company DescriptionChemung Financial Corporation operates as the holding company for Chemung Canal Trust Company that provides a range of banking, financing, fiduciary, and other financial services. The company provides demand, savings, and time deposits; non-interest and interest-bearing checking accounts; and insured money market accounts. It also offers commercial and agricultural loans comprising loans to small to mid-sized businesses; commercial mortgage loans; residential mortgage loans; consumer loans, including home equity lines of credit and home equity term loans; and interest rate swaps, letters of credit, wealth management, employee benefit plans, mutual fund, insurance products, and brokerage services. Further, it provides securities, insurance, and tax preparation services. Additionally, it offers guardian, custodian, and trustee services, as well as acts as an agent for pension, profit-sharing, and other employee benefit trusts; and various investment, pension, estate planning, and employee benefit administrative services. The company operates 31 branch offices located in 13 counties in New York and Bradford County in Pennsylvania. Chemung Financial Corporation was founded in 1833 and is headquartered in Elmira, New York.
How the Company Makes MoneyChemung Financial generates revenue primarily through interest income from loans and investment securities, as well as non-interest income from service fees, wealth management services, and insurance commissions. Key revenue streams include interest earned on mortgages, business loans, and other credit products, which are fundamental to its banking operations. Additionally, the bank collects fees for various services, such as account maintenance and transaction processing. The company also earns money through its investment management and trust services, which provide advisory services and manage client assets for a fee. Strategic partnerships with other financial institutions and service providers further enhance its offerings, contributing to its overall earnings.

Chemung Financial Financial Statement Overview

Summary
Chemung Financial presents a solid financial profile characterized by consistent revenue growth, robust equity position, and effective cash management. While profitability margins have shown some pressure recently, the overall financial health remains strong, supported by low leverage and significant equity growth.
Income Statement
75
Positive
Chemung Financial has demonstrated consistent revenue growth over the years, with a notable increase in total revenue from $86.9 million in 2020 to $150.3 million in TTM (Trailing-Twelve-Months) 2025. The gross profit margin remains strong, averaging around 63%, and the net profit margin has been stable, indicating effective cost management. However, there is a decline in EBIT and EBITDA margins in the TTM period compared to prior years, suggesting potential pressures on operating efficiencies.
Balance Sheet
80
Positive
The balance sheet of Chemung Financial reflects strong equity growth, with stockholders' equity increasing from $199.7 million in 2020 to $228.3 million in TTM 2025. The debt-to-equity ratio remains low, enhancing financial stability, typical for regional banks. The equity ratio is healthy, indicating a robust financial structure and low leverage risk. This stability is crucial for a financial institution, reducing risk exposure.
Cash Flow
70
Positive
Cash flow analysis reveals a positive trend in operating cash flow, which increased significantly from $28.6 million in 2020 to $29.0 million in TTM 2025. The Free Cash Flow to Net Income ratio is favorable, suggesting effective cash management and operational efficiency. However, fluctuations in free cash flow growth indicate some volatility in cash generation, which could affect future liquidity.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue135.84M149.61M136.58M101.91M91.84M86.86M
Gross Profit81.64M96.15M94.70M95.17M88.41M78.63M
EBITDA16.12M32.10M34.30M39.91M37.26M28.13M
Net Income11.21M23.67M25.00M28.78M26.43M19.26M
Balance Sheet
Total Assets2.85B2.78B2.71B2.65B2.42B2.28B
Cash, Cash Equivalents and Short-Term Investments323.16M468.77M620.84M688.46M819.01M663.15M
Total Debt108.08M118.52M40.80M105.76M25.54M11.11M
Total Liabilities2.62B2.56B2.52B2.48B2.21B2.08B
Stockholders Equity234.97M215.31M195.24M166.39M211.46M199.70M
Cash Flow
Free Cash Flow29.11M26.19M30.42M34.62M35.09M27.79M
Operating Cash Flow32.32M29.82M30.88M35.05M35.46M28.66M
Investing Cash Flow152.98M-57.72M-82.38M-252.62M-242.48M-495.85M
Financing Cash Flow64.54M38.10M32.48M246.46M125.47M453.82M

Chemung Financial Technical Analysis

Technical Analysis Sentiment
Positive
Last Price53.22
Price Trends
50DMA
51.75
Positive
100DMA
48.85
Positive
200DMA
48.78
Positive
Market Momentum
MACD
0.64
Negative
RSI
55.30
Neutral
STOCH
37.45
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CHMG, the sentiment is Positive. The current price of 53.22 is above the 20-day moving average (MA) of 52.38, above the 50-day MA of 51.75, and above the 200-day MA of 48.78, indicating a bullish trend. The MACD of 0.64 indicates Negative momentum. The RSI at 55.30 is Neutral, neither overbought nor oversold. The STOCH value of 37.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CHMG.

Chemung Financial Risk Analysis

Chemung Financial disclosed 39 risk factors in its most recent earnings report. Chemung Financial reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Chemung Financial Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
$227.66M10.758.28%5.48%14.84%169.99%
76
Outperform
14.11%29.41%
76
Outperform
$244.78M13.508.60%2.84%7.42%15.82%
72
Outperform
$250.61M22.055.18%2.41%-6.64%-51.99%
68
Neutral
$17.80B11.949.89%3.74%9.69%1.17%
60
Neutral
-6.85%-51.70%
57
Neutral
$275.26M93.080.79%3.58%4.72%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CHMG
Chemung Financial
53.22
8.01
17.72%
EVBN
Evans Bancorp
39.53
4.25
12.05%
LCNB
LCNB
16.00
1.36
9.29%
PWOD
Penns Woods Bancorp
30.00
9.92
49.40%
FRST
Primis Financial
11.16
0.42
3.91%
MBCN
Middlefield Banc
29.26
4.12
16.39%

Chemung Financial Corporate Events

Private Placements and FinancingBusiness Operations and StrategyFinancial Disclosures
Chemung Financial Engages Investors Amid Financial Restructuring
Neutral
Sep 2, 2025

In September 2025, Chemung Financial Corporation’s management plans to engage with institutional investors to discuss strategies and performance. The company has recently undertaken significant financial restructuring, including issuing $45 million in subordinated notes and selling $245.5 million in securities, resulting in a $17.5 million pre-tax loss. These moves aim to optimize the balance sheet, enhance profitability, and support growth strategies, potentially impacting stakeholders positively by improving capital ratios and expanding market presence.

Dividends
Chemung Financial Announces Dividend Increase
Positive
Aug 19, 2025

On August 19, 2025, Chemung Financial Corporation announced a dividend increase of $0.02 per share, resulting in a quarterly cash dividend of $0.34 per share, payable on October 1, 2025, to shareholders of record as of September 17, 2025. This marks the second dividend increase in 2025, representing a 6.3% rise over the previous quarter’s dividend and bringing the total increase for the year to 9.7%.

Private Placements and FinancingBusiness Operations and StrategyFinancial Disclosures
Chemung Financial Highlights Growth at KBW Conference
Positive
Jul 25, 2025

Chemung Financial Corporation announced its participation in the 2025 KBW Community Bank Investor Conference, where management will meet with institutional investors to discuss strategies and recent financial performance. The company highlighted its stable deposit base, strategic balance sheet restructuring, and expansion into higher growth markets like Albany and Buffalo. Recent financial activities include issuing $45 million in subordinated notes and selling $245.5 million in securities, resulting in a $17.5 million pre-tax loss. These moves are expected to enhance profitability metrics and support capital ratios, reflecting a strategic focus on growth and operational efficiency.

Business Operations and StrategyFinancial Disclosures
Chemung Financial Completes Strategic Balance Sheet Repositioning
Negative
Jun 12, 2025

Chemung Financial Corporation announced the completion of a strategic balance sheet repositioning by selling securities worth approximately $242 million, resulting in a pre-tax loss of $17 million to be recognized in the second quarter of 2025. The proceeds will be used to reduce non-core funding liabilities and support loan growth, with expectations of improved financial metrics from the third quarter of 2025, despite reporting a net loss for the second quarter.

Private Placements and FinancingBusiness Operations and Strategy
Chemung Financial Issues $45M Subordinated Notes
Positive
Jun 10, 2025

On June 10, 2025, Chemung Financial Corporation issued $45 million in subordinated notes due 2035 to accredited investors and institutional buyers. This move aims to support the company’s growth initiatives and regulatory capital ratios, potentially involving balance sheet restructuring. The notes, maturing in 2035, will initially bear a fixed interest rate of 7.75% until 2030, after which they will switch to a floating rate. This strategic financial maneuver is expected to enhance Chemung’s capital structure and support its expansion efforts.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 09, 2025